Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
3.370
+0.030 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
3.321
-0.049 (-1.46%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 41.00K | 103.00K | - | - | - | | | | | |
| -60.19% | - | - | - | - | | | | | |
| 56.13M | 79.18M | - | - | - | | | | | |
| -29.11% | - | - | - | - | | | | | |
| 1.50M | 5.23M | - | - | - | | | | | |
| -71.31% | - | - | - | - | | | | | |
Dermatology Products Sales | - | - | 73.67M | 63.13M | 44.53M | | | | | |
Dermatology Products Sales Growth | - | - | 16.69% | 41.78% | 27.52% | | | | | |
Pharmaceutical and Biotechnology Product Development | - | - | 2.07M | 5.66M | 1.07M | | | | | |
Pharmaceutical and Biotechnology Product Development Growth | - | - | -63.34% | 429.68% | -37.47% | | | | | |
| 57.68M | 84.51M | 75.74M | 68.79M | 45.60M | | | | | |
| -31.76% | 11.58% | 10.11% | 50.86% | 24.49% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 57.68M | 84.51M | 75.74M | 68.79M | 45.60M | | | | | |
United States of America Growth | -31.76% | 11.58% | 10.11% | 50.86% | 24.49% | | | | | |
| 57.68M | 84.51M | 75.74M | 68.79M | 45.60M | | | | | |
| -31.76% | 11.58% | 10.11% | 50.86% | 24.49% | | | | | |
Source: S&P Global Market Intelligence.